Razagin 1 mg Tablets
PDF Leaflet Revision Date: Jan 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of idiopathic Parkinson's disease.
Dosage (summary)
1 mg once daily, with or without levodopa.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- MAO inhibitors
- Pethidine
- Fluoxetine
- Fluvoxamine
- Dextromethorphan
Contraindications
- Hypersensitivity
- Moderate or severe hepatic impairment
Common side effects
- Headache
- Depression
- Vertigo
- Dyskinetic movements
- Orthostatic hypotension
Counselling Points
- Avoid driving if experiencing drowsiness
- Monitor for impulse control disorders
- Caution with other CNS depressants
Serious warnings
- Impulse control disorders
- Melanoma risk
- Excessive daytime sleepiness
Important Disclaimer
The Razagin 1 mg Tablets professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
